Company Profile
Updated: 17-SEP-09Archemix Corp.
Private Company, Headquarters Location
300 3rd St., Cambridge, MA 02139-1103, United States
(617)621-7700, (617)621-9300 fax, http://www.archemix.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: A biopharmaceutical company committed to the discovery and development of aptamer-bases therapeutics.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
$37M Addition Brings Archemix Series A Financing To $51.75M.
BIOWORLD Today; 11/4/2009; 707 words; Staff Writer Archemix Corp. completed a Series A round that began...will be used, said Martin Stanton, Archemix president and a company founder...November 2001, Cambridge, Mass.-based Archemix licensed the aptamer technology from...
Appointments And Advancements.
BIOWORLD Today; 11/4/2009; 1015 words; ...Susan Wyant. Advanced Viral Research Corp., of Yonkers, N.Y., added...president and chief information officer. Archemix Corp., of Cambridge, Mass., appointed...chief operating officer. Connetics Corp., of Palo Alto, Calif., appointed...
Archemix Nails Down Two Deals; $29.8M From Merck.
BIOWORLD Today; 11/3/2009; 1064 words; ...Coast Editor Aptamer-focused Archemix Inc. added to a deal spree...Souza, president and CEO of Archemix. The latest deal includes...that an earlier deal with Elan Corp. plc includes a co-development...s division, Merck Serono, Archemix's Selex technology will help...
Archemix Signs Aptamer Deal With Elan For Up To $350M.
BIOWORLD Today; 11/3/2009; 1049 words; Staff Writer In one of its largest deals to date, Archemix Corp. partnered with Irish firm Elan Corp. plc to develop...will work together over the course of three years, with Archemix providing its aptamer technology and Dublin-based Elan...
Other News To Note.
BIOWORLD Today; 11/3/2009; 2419 words; ...expects to report results in late 2005 or early 2006. o Archemix Corp., of Cambridge, Mass., received an undisclosed milestone...11 cents to close at 56 cents. o Generex Biotechnology Corp., of Toronto, said its subsidiary, Antigen Express...
Recent News Articles
- Archemix Corp.-Company Report.
M2 Presswire - February 08, 2009 - FierceBiotech Names Archemix Corp. as One of the "Fierce 15" Biotech Companies of 2007.
Business Wire - June 06, 2007 - Nuvelo and Archemix expand aptamer accord.(research agreements between Archemix Corp and Nuvelo Inc)(Brief article)
Pharma Marketletter - August 14, 2006 - Archemix Corp. Strengthens its Board of Directors Adding Alnylam President and CEO, John Maraganore, Ph.D.
PR Newswire - May 31, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning